Jewish General Hospital; Research Unit

Montreal, Quebec H3T 1E2

0 studies enrolling now · 2 studies all time

What they study most

Lymphoma, Non-Hodgkin, Triple-Negative Breast Cancer

Studies at this site

• A Study of Ipatasertib in Combination With Atezolizumab and Paclitaxel as a Treatment for Participants With Locally Advanced or Metastatic Triple-Negative Breast Cancer — Completed
• A Study Evaluating the Safety, Efficacy and Pharmacokinetics of Venetoclax Combined With Chemotherapy in Participants With B-Cell Non-Hodgkin's Lymphoma (NHL) and DLBCL — Completed